Search Results - Edel Del Barco
- Showing 1 - 10 results of 10
-
1
Severe Hyponatremia Masking Central Diabetes Insipidus in a Patient with a Lung Adenocarcinoma by Eduardo Terán Brage, Manuel Heras Benito, Marta Belén Navalón Jiménez, Rosario Vidal Tocino, Edel del Barco Morillo, Emilio Fonseca Sánchez
Published in Case Reports in Oncology (2022-02-01)Get full text
Article -
2
Complications secondary to the use of SGLT2 inhibitors in oncological patients: a series of 5 cases by Luis Posado-Domínguez, Luis Figuero-Pérez, María Aranzazu Amores-Martin, Pablo Reguera-Puertas, María Martín-Galache, Edel Del Barco-Morillo, Emilio Fonseca-Sánchez
Published in European Journal of Case Reports in Internal Medicine (2023-12-01)Get full text
Article -
3
Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review by Elísabet González del Portillo, Alejandro Olivares-Hernández, Luis Corral Gudino, Laura Corvo Félix, Lorena Bellido Hernández, Luis Posado Domínguez, David León Jiménez, Rogelio González Sarmiento, Edel del Barco Morillo, Emilio Fonseca Sánchez, José Pablo Miramontes-Gonzáleze
Published in Clinical and Translational Radiation Oncology (2025-05-01)Get full text
Article -
4
Corrigendum to “Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review” [Clin. Translat. Radiat. Oncol. 52 (2025) 100930] by Elísabet González del Portillo, Alejandro Olivares-Hernández, Luis Corral-Gudino, Laura Corvo Félix, Lorena Bellido Hernández, Luis Posado Domínguez, David León Jiménez, Rogelio González Sarmiento, Edel del Barco Morillo, Emilio Fonseca Sánchez, José Pablo Miramontes-González
Published in Clinical and Translational Radiation Oncology (2025-07-01)Get full text
Article -
5
The Impact of Liquid Biopsies Positive for <em>EGFR</em> Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients by Jonnathan Roldan Ruiz, Marta Gracia Fuentes Gago, Luis Miguel Chinchilla Tabora, Idalia Gonzalez Morais, José María Sayagués, Mar Abad Hernández, Maria Rosa Cordovilla Pérez, Maria Dolores Ludeña de la Cruz, Edel del Barco Morillo, Marta Rodriguez Gonzalez
Published in Diagnostics (2023-07-01)Get full text
Article -
6
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis by Alejandro Olivares-Hernández, Edel del Barco Morillo, Carmen Parra Pérez, José Pablo Miramontes-González, Luis Figuero-Pérez, Teresa Martín-Gómez, Roberto Escala-Cornejo, Lorena Bellido Hernández, Rogelio González Sarmiento, Juan Jesús Cruz-Hernández, María Dolores Ludeña de la Cruz
Published in Biomedicines (2022-02-01)Get full text
Article -
7
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck by Jordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, Maria Plana Serrahima, Almudena García Castaño, Alberto Carral Maseda, Lara Iglesias Docampo, Pedro Pérez Segura, Isaac Ceballos Lenza, Vanesa Gutiérrez Calderón, José Fuster Salvà, Carolina Pena Álvarez, Irene Hernandez, Edel del Barco Morillo, Manuel Chaves Conde, Joaquina Martínez Galán, Marisa Durán Sánchez, Vanesa Quiroga, Eugenia Ortega, Ricard Mesia, Ricard Mesia
Published in Frontiers in Oncology (2023-08-01)Get full text
Article -
8
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmu... by Amelia Insa, Mariano Provencio, Bartomeu Massutí, Margarita Majem, Delvys Rodriguez-Abreu, Manuel Cobo, Manuel Dómine, Ernest Nadal, Belén Sierra-Rodero, Alberto Cruz-Bermúdez, Alex Martinez-Marti, Javier De Castro Carpeño, Guillermo López Vivanco, Edel Del Barco, Nuria Viñolas, Isidoro Barneto Aranda, Marta Casarrubios, Atocha Romero, Reyes Bernabe, María del Rosario García-Campelo, Martín Lázaro-Quintela, Cristina Martinez-Toledo, Ismael Fernández-Miranda, Roberto Serna-Blanco, Virginia Calvo
Published in Journal for ImmunoTherapy of Cancer (2022-09-01)Get full text
Article -
9
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study by Cristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, Manuel Cobo, José Manuel Trigo, Enric Carcereny, Marc Cucurull, Rafael López Castro, Eduardo Solís García, Amparo Sánchez-Gastaldo, Bartomeu Massutí, Delvys Rodríguez-Abreu, Anna Estival, María Guirado Risueño, María Pamiés Ramón, Rosario García Campelo, Guillermo Alonso-Jáudenes, Carlos Camps, Edel del Barco Morillo, Clara González Ojea, Manuel Dómine, Alfredo Sanchez-Hernandez, Joaquím Bosch-Barrera, María Ángeles Sala González, Mariano Provencio
Published in ERJ Open Research (2023-12-01)Get full text
Article -
10
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial by Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García‐Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra‐Rodero, Carlos Tarín, Aránzazu García‐Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio
Published in Clinical and Translational Medicine (2021-07-01)Get full text
Article
